LCQ LCQ Research and Evidence Base 2 — Questions and Answers
Question 1: What did cross-cultural validation studies of the LCQ confirm?
- Translated versions maintain psychometric properties comparable to the original English LCQ (Correct answer)
- Translated versions perform poorly outside the UK
- The LCQ is only valid in English-speaking countries
- Cross-cultural validation has not been attempted
Correct answer: Translated versions maintain psychometric properties comparable to the original English LCQ
Cross-cultural adaptation studies have confirmed that translated LCQ versions in languages including Spanish, Chinese, Italian, and others retain acceptable psychometric properties.
Question 2: In LCQ validation studies, what criterion validity method is typically used?
- Correlation with other established cough QoL tools and objective cough counts (Correct answer)
- Comparison against blood tests
- Validation against chest X-ray findings
- Correlation with FEV1 values
Correct answer: Correlation with other established cough QoL tools and objective cough counts
Criterion validity of the LCQ is established by correlating its scores with other validated cough quality of life measures and objective cough frequency data.
Question 3: What has research shown about the correlation between LCQ scores and objective cough frequency?
- Modest-to-moderate correlation, indicating they measure related but distinct constructs (Correct answer)
- Perfect correlation (r=1.0)
- No significant correlation
- Strong inverse correlation
Correct answer: Modest-to-moderate correlation, indicating they measure related but distinct constructs
Research shows a modest-to-moderate correlation between LCQ scores and objective cough frequency, confirming that subjective QoL impact and objective frequency are related but not identical.
Question 4: What did studies of the LCQ in clinical trials of gefapixant (P2X3 antagonist) demonstrate?
- Significant LCQ score improvements correlating with reduced cough frequency (Correct answer)
- No change in LCQ scores with gefapixant
- LCQ could not detect drug-related changes
- LCQ was not used in gefapixant trials
Correct answer: Significant LCQ score improvements correlating with reduced cough frequency
Clinical trials of gefapixant demonstrated significant improvements in LCQ scores alongside reductions in cough frequency, further validating the LCQ's responsiveness to pharmacotherapy.
Question 5: Which statistical property of the LCQ has been most consistently replicated across validation studies?
- High internal consistency (Cronbach's alpha >0.85) (Correct answer)
- Low test-retest reliability
- Poor cross-cultural validity
- Absence of floor and ceiling effects
Correct answer: High internal consistency (Cronbach's alpha >0.85)
The LCQ's high internal consistency (Cronbach's alpha consistently >0.85–0.90) is the most replicated psychometric property across multiple independent validation studies.
Question 6: What did a systematic review of chronic cough outcome measures conclude about the LCQ?
- The LCQ is one of the most widely used and well-validated chronic cough QoL tools (Correct answer)
- The LCQ lacks sufficient validation for routine use
- The LCQ should be replaced by newer tools
- Only the physical domain of the LCQ meets validation standards
Correct answer: The LCQ is one of the most widely used and well-validated chronic cough QoL tools
Systematic reviews of chronic cough outcome measures consistently identify the LCQ as among the best-validated and most widely used patient-reported outcome tools in the field.
LCQ LCQ Research and Evidence Base 2
What did cross-cultural validation studies of the LCQ confirm?